Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 702,073	$ 613,110
Trade accounts receivable, less allowance for doubtful accounts (2020 – $2,154; 2019 – $3,711)	516,166	612,651
Other accounts receivable	61,522	67,551
Inventories	828,080	768,984
Other current assets	119,171	162,813
Total current assets	2,227,012	2,225,109
Property, plant and equipment, at cost	7,284,575	6,817,843
Less accumulated depreciation and amortization	2,041,851	1,908,370
Net property, plant and equipment	5,242,724	4,909,473
Investments	603,745	579,813
Other assets	211,534	213,061
Goodwill	1,603,049	1,578,785
Other intangibles, net of amortization	343,919	354,622
Total assets	10,231,983	9,860,863
Current liabilities:
Accounts payable	465,644	574,138
Accrued expenses	477,510	576,297
Current portion of long-term debt	603,787	187,336
Dividends payable	40,787	38,764
Accrued expenses	18,013	23,137
Income taxes payable	25,011	32,461
Total current liabilities	1,612,739	1,408,996
Long-term debt	2,940,533	2,862,921
Postretirement benefits	49,926	50,899
Pension benefits	285,942	292,073
Other noncurrent liabilities	612,013	754,536
Deferred income taxes	405,449	397,858
Commitments and contingencies (Note 9)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 106,457 in 2020 and 106,040 in 2019	1,065	1,061
Additional paid-in capital	1,410,534	1,383,446
Accumulated other comprehensive loss	(398,467)	(395,735)
Retained earnings	3,111,749	2,943,478
Total Albemarle Corporation shareholders’ equity	4,124,881	3,932,250
Noncontrolling interests	200,500	161,330
Total equity	4,325,381	4,093,580
Total liabilities and equity	$ 10,231,983	$ 9,860,863